BMS sues AstraZeneca over cancer treatment drug

The US pharma giant says that a competitor’s drug infringes two patents related to its blockbuster checkpoint inhibitor medicine.

Amgen v Sanofi: a key SCOTUS decision

As patent attorneys look ahead to this year’s pivotal rulings, Timothy Sendek of Akerman offers insights on the pending enablement case.

Blank Rome hires new patent agent for Texas office

The new addition’s expertise spans mechanical, electrical, chemical, nanotechnology, biotechnology, medical devices and optics.

LSIPR